A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a new study shows.
Researchers suggest targeting ECM-mediated regulation of autophagy levels could be used to sensitize pancreatic cancer to FDA-approved therapies.
This infographic explores the core components of the TME, their roles in cancer progression and how they can be leveraged to ...
The partnership combines RRG’s FDA-registered, CLIA-certified laboratory and industry-leading biologic products with ...
A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a ...
Researchers show how damaged tissue is reshaped to trigger painful bone formation in muscles and tendons CHINA, ...
Explore the risks of postpartum cancer and discover how cellular senescence affects breast tissue after pregnancy.
Dr Ravya Khanna, M.D. at Georgetown University Medical Center, warns of the potential side effects of consuming unprocessed ...
A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a new study shows. The ability of these cancer cells to adapt quickly and ...
Devonian Health Group Inc. ("Devonian" or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced positive results from a follow-up preclinical study evaluating Thykamine™ in a human ...